EDITORIAL
Published on 11 May 2015
Editorial: Multidrug Resistance in Cancer: Pharmacological Strategies from Basic Research to Clinical Issues
doi 10.3389/fonc.2015.00105
- 3,385 views
- 22 citations
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Multidrug resistance in Cancer: Pharmacological Strategies from Basic Research to Clinical Issues
Multidrug resistance in Cancer: Pharmacological Strategies from Basic Research to Clinical Issues
23k
Total downloads
109k
Total views and downloads
Articles
OPINION
Published on 23 Dec 2014
Is redox signaling a feasible target for overcoming multidrug resistance in cancer chemotherapy?
doi 10.3389/fphar.2014.00286
- 6,233 views
- 19 citations
REVIEW
Published on 10 Jul 2014
ABC transporters in CSCs membranes as a novel target for treating tumor relapse
doi 10.3389/fphar.2014.00163
- 7,010 views
- 64 citations
METHODS
Published on 06 Mar 2014
In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies
doi 10.3389/fonc.2014.00040
- 62,154 views
- 238 citations
REVIEW
Published on 03 Mar 2014
Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function
doi 10.3389/fonc.2014.00041
- 17,063 views
- 229 citations
REVIEW
Published on 21 Jan 2014
Small and Innovative Molecules as New Strategy to Revert MDR
doi 10.3389/fonc.2014.00002
- 7,097 views
- 76 citations
MINI REVIEW
Published on 30 Dec 2013
Where is it and How Does it Get There – Intracellular Localization and Traffic of P-glycoprotein
doi 10.3389/fonc.2013.00321
- 7,483 views
- 54 citations
ORIGINAL RESEARCH
Published on 07 Nov 2013
ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity
doi 10.3389/fphar.2013.00138
- 4,593 views
- 15 citations
ORIGINAL RESEARCH
Published on 04 Nov 2013
P-glycoprotein mediated efflux limits substrate and drug uptake in a preclinical brain metastases of breast cancer model
doi 10.3389/fphar.2013.00136
- 7,429 views
- 59 citations
OPINION
Published on 25 Oct 2013
Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?
doi 10.3389/fphar.2013.00134
- 10,229 views
- 37 citations
Published in
Frontiers in Oncology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore